Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Huron Gastroenterology Associates
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Westwood, KS
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Woodland, CA
Click here to add this to my saved trials
Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Hematology Clinical Trial
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 0360014
mi
from
Melbourne,
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
Boise, ID
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
Howell, NJ
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
Syracuse, NY
Click here to add this to my saved trials
Neoplasms Clinical Trial
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Inova Schar Cancer Institute
mi
from
Fairfax, VA
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Florida Cancer Affiliates
mi
from
Ocala, FL
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease
Status: Enrolling, Phase IV
Updated: 3/15/2016
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Wisconsin Cancer Center
mi
from
Ashland, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Our Lady of the Lake Physicians Group - Medical Oncology
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Mills-Peninsula Medical Center
mi
from
Burlingame, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Caro Cancer Center
mi
from
Caro, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Beaumont Hospital-Dearborn
mi
from
Dearborn, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
mi
from
Decatur, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Palo Alto Medical Foundation-Fremont
mi
from
Fremont, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Care Cancer Center - Garden City
mi
from
Garden City, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Care Cancer Center - Great Bend
mi
from
Great Bend, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Cancer Care Inc-POB II
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Franciscan Health Indianapolis
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Vidant Oncology-Kenansville
mi
from
Kenansville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Sechler Family Cancer Center
mi
from
Lebanon, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Hope Cancer Clinic
mi
from
Livonia, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Centra Lynchburg Hematology Oncology Clinic
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Chancellor Center for Oncology
mi
from
Newburgh, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Nebraska Cancer Specialists - Omaha
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Ontario
mi
from
Ontario, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Presbyterian Rust Medical Center/Jorgensen Cancer Center
mi
from
Rio Rancho, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Rochester Hills
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health Sandstone
mi
from
Sandstone, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
HSHS Saint Nicholas Hospital
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Marshfield Clinic Stevens Point Center
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Macomb Hematology Oncology PC
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Ann Arbor
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Pharmacy Department
mi
from
Bronx, NY
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut Children's Medical Center Pharmacy
mi
from
Hartford, CT
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Children's Hospital- Main Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Arkansas Children's Hospital - Attention: Jill Hernandez
mi
from
Little Rock, AR
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Rady Children's Hospital Center for Pediatric Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis Clinical Trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Status: Enrolling, Phase III
Updated: 12/31/1969
Rady Children's Hospital Rheumatology Clinic
mi
from
San Diego, CA
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling, Phase III
Updated: 4/7/2016
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling, Phase III
Updated: 4/7/2016
Clinical Research Facility
mi
from
Harvey, IL
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling, Phase III
Updated: 4/7/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling, Phase III
Updated: 4/7/2016
Clinical Research Facility
mi
from
Scarborough, ME
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling, Phase II
Updated: 9/23/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling, Phase II
Updated: 9/23/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling, Phase II
Updated: 9/23/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling, Phase II
Updated: 9/23/2015
Clinical Research Facility
mi
from
Easton, PA
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling, Phase II
Updated: 9/23/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling, Phase II
Updated: 9/23/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling, Phase II
Updated: 9/23/2015
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling, Phase III
Updated: 9/23/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling, Phase III
Updated: 9/23/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling, Phase III
Updated: 9/23/2015
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Gastroparesis Clinical Trial
The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
Status: Enrolling, Phase II
Updated: 12/12/2016
Digestive Research Center Gastroenterology Consultants of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)
Status: Enrolling, Phase I
Updated: 4/7/2016
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Chronic Hepatitis C Virus Infection Clinical Trial
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With and Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
Status: Enrolling, Phase II
Updated: 4/14/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Salivary Biomarkers for Non-small Cell Lung Cancer Detection
Status: Enrolling, Phase
Updated: 4/10/2018
Main Line Health Ststem
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center (KUMC)
mi
from
Kansas City, KS
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
Status: Enrolling
Updated: 12/31/1969
John Wayne Cancer Institute @ Providecne St. Johns Health Center
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Richard M Schulze Family Foundation Outpatient Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Hypertension Clinical Trial
Chronic Hypertension and Pregnancy (CHAP) Project
Status: Enrolling, Phase IV
Updated: 12/31/1969
New York-Presbyterian/Queens
mi
from
Flushing, NY
Click here to add this to my saved trials
Hypertension Clinical Trial
Chronic Hypertension and Pregnancy (CHAP) Project
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Pittsburg/Magee Women's Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Status: Enrolling, Phase I
Updated: 12/31/1969
Gainesville Clinical Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
Melanoma Clinical Trial
Phase IIB TL + YCWP + DC in Melanoma
Status: Enrolling, Phase II
Updated: 12/31/1969
The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
Phase IIB TL + YCWP + DC in Melanoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Mount Sinai Cancer Research Program
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Melanoma Clinical Trial
Phase IIB TL + YCWP + DC in Melanoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Mayo Clinic - Cancer Clinical Research Office
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study
Status: Enrolling, Phase I
Updated: 12/31/1969
McMaster Children's Hospital
mi
from
Hamilton,
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas
Status: Enrolling, Phase I, II
Updated: 12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Liver Cirrhosis, Biliary Clinical Trial
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Baylor College of Medicine - Advanced Liver Therapies
mi
from
Houston, TX
Click here to add this to my saved trials
Cushings Disease Clinical Trial
Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Montreal,
Click here to add this to my saved trials
Clinical Trial
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Clinical Trial
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Smilow Cancer Hospital-Torrington Care Center
mi
from
Torrington, CT
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry, Other Clinical Trial
Exoskeletal-assisted Walking to Improve Mobility, Bowel Function and Cardio-Metabolic Profiles in Persons With SCI
Status: Enrolling
Updated: 8/21/2017
James J Peteres VA Medical Center
mi
from
The Bronx, NY
Click here to add this to my saved trials
Acute Pain Clinical Trial
An Efficacy and Safety Study of Tapentadol in the Treatment of Post-operative Acute Pain Requiring Opioid Treatment in Pediatric Participants
Status: Enrolling, Phase III
Updated: 12/31/1969
US009
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Intracranial Vascular Disorders Clinical Trial
Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Northwestern University Department of Radiology
mi
from
Chicago, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Cooper Univ. Hosp. CRS
mi
from
Camden, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Miami Infectious Disease Research Unit at Jackson Memorial Hospital CRS
mi
from
Miami, FL
Click here to add this to my saved trials